Patent · US Expired

Steroidal antiestrogens and antiandrogens and uses thereof

US7041839B2 · kind B2 · utility

0Cited by
5References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2001
Grant dateMay 9, 2006
Priority date
Expiry dateJun 29, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J71/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention comprises the design, synthesis and development of a new class of chemotherapeutic agents for prophylactic and therapeutic treatments in a mammal, particularly a human, believed to be at risk of suffering from a hormone-responsive disorde. In an embodiment of the invention, such treatments include therapeutic compositions comprising novel steroidal antiestrogen and antiandrogen compounds. In a preferred embodiment, such a novel compound of the present invention has an address and a message component, which are made into a single composite entity for more aggressive intervention and effective treatment of hormone-responsive disorders, thereby prolonging the disease-free interval for the patient and reducing a number of side effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.